flow trial semaglutide nejm ✍️✓🆕A pathbreaking published in @NEJM today 👍FLOW Trial 💉in Diabetic CKD 🫡Significant benefits in renal and cardiovascular outcomes @ERAkidney #ERA24 @NEJM Semaglutide could be 'practice changing'

They also check for creatine kinase

The verdict Conditional on most plans Blue Shield of California restricts new Wegovy weight-loss starts to BMI 40 or higher (Class III/morbid obesity) since January 1, 2025 meaning patients at BMI 3039 who otherwise qualify under the FDA label are excluded from new weight-loss coverage

This makes it less likely that combining them would cause major drug interactions

Insulin resistance Around 65 to 70% of people with PCOS have insulin resistance, which increases fat storage, making it more difficult to break down fat and control blood sugar levels

Should I have conservative therapy before surgery for lipedema